Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Address correspondence to: Siamon Gordon, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX13RE, United Kingdom. Phone: 44-1865-275534; Fax: 44-1865-275515; E-mail: firstname.lastname@example.org email@example.com.
Published January 2, 2007 - More info
Monocytes participate critically in atherosclerosis. There are 2 major subsets expressing different chemokine receptor patterns: CCR2+CX3CR1+Ly-6Chi and CCR2–CX3CR1++Ly-6Clo monocytes. Both C-C motif chemokine receptor 2 (CCR2) and C-X3-C motif chemokine receptor 1 (CX3CR1) are linked to progression of atherosclerotic plaques. Here, we analyzed mouse monocyte subsets in apoE-deficient mice and traced their differentiation and chemokine receptor usage as they accumulated within atherosclerotic plaques. Blood monocyte counts were elevated in apoE–/– mice and skewed toward an increased frequency of CCR2+Ly-6Chi monocytes in apoE–/– mice fed a high-fat diet. CCR2+Ly-6Chi monocytes efficiently accumulated in plaques, whereas CCR2–Ly-6Clo monocytes entered less frequently but were more prone to developing into plaque cells expressing the dendritic cell–associated marker CD11c, indicating that phagocyte heterogeneity in plaques is linked to distinct types of entering monocytes. CCR2– monocytes did not rely on CX3CR1 to enter plaques. Instead, they were partially dependent upon CCR5, which they selectively upregulated in apoE–/– mice. By comparison, CCR2+Ly-6Chi monocytes unexpectedly required CX3CR1 in addition to CCR2 and CCR5 to accumulate within plaques. In many other inflammatory settings, these monocytes utilize CCR2, but not CX3CR1, for trafficking. Thus, antagonizing CX3CR1 may be effective therapeutically in ameliorating CCR2+ monocyte recruitment to plaques without impairing their CCR2-dependent responses to inflammation overall.
Frank Tacke, David Alvarez, Theodore J. Kaplan, Claudia Jakubzick, Rainer Spanbroek, Jaime Llodra, Alexandre Garin, Jianhua Liu, Matthias Mack, Nico van Rooijen, Sergio A. Lira, Andreas J. Habenicht, Gwendalyn J. Randolph
Adipose tissue macrophages (ATMs) infiltrate adipose tissue during obesity and contribute to insulin resistance. We hypothesized that macrophages migrating to adipose tissue upon high-fat feeding may differ from those that reside there under normal diet conditions. To this end, we found a novel F4/80+CD11c+ population of ATMs in adipose tissue of obese mice that was not seen in lean mice. ATMs from lean mice expressed many genes characteristic of M2 or “alternatively activated” macrophages, including Ym1, arginase 1, and Il10. Diet-induced obesity decreased expression of these genes in ATMs while increasing expression of genes such as those encoding TNF-α and iNOS that are characteristic of M1 or “classically activated” macrophages. Interestingly, ATMs from obese C-C motif chemokine receptor 2–KO (Ccr2-KO) mice express M2 markers at levels similar to those from lean mice. The antiinflammatory cytokine IL-10, which was overexpressed in ATMs from lean mice, protected adipocytes from TNF-α–induced insulin resistance. Thus, diet-induced obesity leads to a shift in the activation state of ATMs from an M2-polarized state in lean animals that may protect adipocytes from inflammation to an M1 proinflammatory state that contributes to insulin resistance.
Carey N. Lumeng, Jennifer L. Bodzin, Alan R. Saltiel
Macrophage accumulation participates decisively in the development and exacerbation of atherosclerosis. Circulating monocytes, the precursors of macrophages, display heterogeneity in mice and humans, but their relative contribution to atherogenesis remains unknown. We report here that the Ly-6Chi monocyte subset increased dramatically in hypercholesterolemic apoE–deficient mice consuming a high-fat diet, with the number of Ly-6Chi cells doubling in the blood every month. Ly-6Chi monocytes adhered to activated endothelium, infiltrated lesions, and became lesional macrophages. Hypercholesterolemia-associated monocytosis (HAM) developed from increased survival, continued cell proliferation, and impaired Ly-6Chi to Ly-6Clo conversion and subsided upon statin-induced cholesterol reduction. Conversely, the number of Ly-6Clo cells remained unaffected. Thus, we believe that Ly-6Chi monocytes represent a newly recognized component of the inflammatory response in experimental atherosclerosis.
Filip K. Swirski, Peter Libby, Elena Aikawa, Pilar Alcaide, F. William Luscinskas, Ralph Weissleder, Mikael J. Pittet
Macrophages are present as resident cells in adipose tissue, and blood monocytes are recruited in increased numbers to sites of lipid accumulation in atherosclerosis, a modified form of inflammation in the arterial wall. Recent findings reported by 3 separate groups in this issue of the JCI provide evidence for distinct monocyte subsets, differential chemokine receptor usage, and phenotypic modulation of macrophages in murine models of genetic and high-fat diet–induced disease (see the related articles beginning on pages 175, 185, and 195). These studies raise prospects for selective therapeutic targets to ameliorate macrophage hyperinflammatory responses, while sparing host defense and repair mechanisms.
Monocytes and mature macrophages are prominent in the host response to lipid accumulation in major arteries, the development of atherosclerotic plaques, and their complications (1). Less established are the details of their colocalization and possible metabolic interactions with adipocytes in body fat stores (2). New studies reported in this issue of the JCI by Swirski et al. (3) demonstrate that a monocyte subset that expresses high levels of a marker antigen, Ly-6C, dominates hypercholesterolemia-associated monocytosis and gives rise to macrophages in atheromata. Also in this issue, Tacke et al. (4) report that monocyte subsets differentially employ the chemokine receptors C-C motif chemokine receptor 2 (CCR2), CCR5, and C-X3-C motif chemokine receptor 1 (CX3CR1, also known as the fractalkine receptor) to enter atherosclerotic plaques. They also exploited an mAb, Gr-1, directed against Ly-6 family antigens to distinguish monocyte subsets and used CD11c, a β2 integrin expressed by myeloid DCs and selected tissue macrophages, to characterize the phenotype of macrophage subpopulations in lesions. In the third of this trio of articles, Lumeng et al. (5), by contrast, document that adipose tissue macrophages, which accumulate with obesity and are implicated in insulin resistance, switch their phenotype from one of an alternatively activated (M2) polarization to proinflammatory (M1) cells and that a subset of these cells expresses elevated levels of the CD11c marker. Collectively, these studies extend our knowledge of heterogeneity of monocyte recruitment and the macrophage phenotype in response to different inflammatory and metabolic stimuli and reinforce the importance of macrophage interactions with adipocytes, as well as with endothelium, smooth muscle, and other cells in the lipid-rich tissue microenvironment.
Lipid-laden macrophages, known as foam cells, play a central role in the pathogenesis and repair of atherosclerotic plaques, the product of local cellular inflammatory reactions in arterial walls (6). Macrophages have also been implicated in plaque vulnerability to rupture and thrombus formation. Their recruitment depends on circulating monocyte levels and is greatly reduced in M-CSF–deficient osteopetrotic mice, which display a variable deficiency of tissue macrophage populations in the absence of this important growth and survival factor (7). Recently, interest has grown in the observations by several groups that circulatory monocytes express distinctive chemokine receptors, particularly with respect to CX3CR1 and CCR2 (also known as receptor for monocyte chemoattractant protein 1 [MCP-1]), as well as antigen markers such as Gr-1; CD14, a receptor for LPS-binding protein; and CD16, an Fc receptor (8, 9). Figure 1 summarizes the present consensus that different monocyte subsets give rise to constitutively present, resident macrophages and to tissue macrophages that have been recruited in increased numbers to local sites of infection and immunologic injury. There is evidence that this distinctive recruitment property of CD14+CD16+, which is not present in CD14++CD16– monocytes, mediated by CX3CR1hiCCR2–CD62 ligand– (CX3CR1hiCCR2–CD62L–) and CX3CR1loCCR2+CD62L+ subpopulations, respectively, is conserved in several species, including mice and humans. While the origin of microbially elicited, acute inflammatory macrophages is more readily demonstrable experimentally, the sources of resident tissue macrophages, which turn over more slowly, are less clear. The origins of nonclassical inflammatory macrophages elicited by metabolic stimuli, such as modified (lipo)proteins in atherosclerosis, diabetes mellitus, and Alzheimer disease, have not been hitherto characterized.
Heterogeneity of monocytes and tissue macrophages. This schematic summarizes previous evidence for monocytic subsets giving rise to tissue macrophages and myeloid DCs in the absence and presence of microbially elicited inflammation. Two distinct subpopulations of monocytes can be identified in the circulation, CD14+CD16+ versus CD14++CD16– in the human and Ly-6lo/Gr-1lo versus Ly-6hi/Gr-1hi in the mouse. There are also differences in expression of CX3CR1 (fractalkine receptor), CCR2, and CD62L (L selectin ligand). Experimental studies in rodents have shown that the CX3CR1lo subset gives rise to recruited macrophages and DCs, in response to a proinflammatory stimulus, whereas the CX3CR1lo subset may give rise to resident tissue cells.
Once present in tissues, mature macrophages exhibit another level of heterogeneity. Microbial stimuli acting through a variety of TLRs and non-TLRs, such as dectin-1, induce a range of transcriptional and nontranscriptional effector responses (known as innate activation) (9, 10). The cytokine IFN-γ induces a signature of proinflammatory antimicrobial activities (known as classical activation) that are important in cell-mediated immunity to intracellular pathogens and are associated with Th1 lymphocyte responses. A distinctive, “alternative activation” profile is associated with Th2-type polarized responses. Characteristic features of IL-4– and IL-13–induced (M2) phenotypes include enhanced MHC class II expression, as in IFN-γ–induced M1 macrophages, but distinctive upregulation of endocytic lectin-like receptors (e.g., the mannose receptor) and of arginase, rather than inducible NOS2 (Table 1). Alternative activation is strongly associated with extracellular parasitic infections, allergy, humoral immunity, and fibrosis. Macrophage deactivation is equally complex and characterized by distinctive, partially overlapping signatures of gene expression induced by IL-10, glucocorticoids, TGF-β, and other regulatory mediators.
Modulation of macrophage phenotype
A further level of heterogeneity to consider relates to the origin, differentiation, and activation of myeloid DCs (11). These cells arise from common progenitors and share many phenotypic characteristics with macrophages, namely phagocytosis, receptor expression, and cytokine secretion, but acquire a unique antigen-presenting capacity for naive T lymphocytes as they undergo a complex process of maturation. They become actively migratory cells, responding to selected chemokines as they deliver antigen to draining lymph nodes. However, DCs display considerable heterogeneity in lymphoid and nonlymphoid tissues, which has been difficult to establish in situ, rather than in the simpler in vitro model systems that are widely employed, and they express many apparently selective markers, such as CD11c, also expressed by tissue macrophages.
The distinction drawn between innate immunity and lipid homeostasis is artificial and is breaking down. For example, TNF-α, the prototypical proinflammatory cytokine that is critical for host defense, has direct effects on metabolic pathways including lipid metabolism, as originally described by Cerami and colleagues and termed cachectin (12). The scavenger receptors expressed mainly by macrophages and endothelia are implicated in innate recognition of microorganisms, as well as in foam cell formation and uptake of modified lipoproteins and of apoptotic cells (13). Circulating lipoproteins, their cellular receptors and lipid transfer proteins, play an important role in LPS-induced responses, TLR stimulation, activation of intracellular signaling pathways, especially of NF-κB, and activation of gene expression. The roles of nuclear receptors such as PPARγ in inflammation and of lipid metabolites in the initiation and resolution of inflammation fall outside the scope of this commentary. Recently, interest has grown in the possible interactions between macrophages and adipocytes, involving cytokines such as leptin, adiponectin, and effects of these and other paracrine mediators on insulin responses and signaling.
The study in this issue by Swirski et al. (3) utilized apoE-KO (apoE–/–) mice on a C57BL/6 background, fed a high-fat “Western” diet over a period of many weeks to induce an increase in atheromatous lesions throughout the aorta. The authors characterized monocyte numbers mainly in blood and spleen, as well as in bone marrow, and distinguished their phenotype from that of more mature splenic macrophages. (In rodents, the spleen is also a major hemopoietic organ). Hypercholesterolemia was associated with gradual monocytosis, with a doubling time of approximately 1 month, due to a selective increase in the Ly-6C–positive subset. Monocytosis was ascribed to increased survival and continued proliferation, in part due to M-CSF, as well as impaired conversion of Ly-6Chi to Ly-6Clo cells; monocytosis decreased upon statin-induced reduction of cholesterol. Clodronate-laden liposomes were used to deplete monocytes and macrophages in vivo. The recovery of Ly-6Clo monocyte numbers, presumably from Ly-6Chi precursors, occurred over 5 days in animals on a control chow diet but was impaired in the hypercholesterolemic mice. Monocytes recovered from enzyme-digested aortas and analyzed by FACS showed preferential accumulation of Ly-6Chi cells, especially in more severe lesions, localized by immunocytochemistry. Experiments confirmed that Ly-6Chi monocytes adhered preferentially to TNF-α–activated endothelium under laminar flow conditions in vitro, irrespective of diet or apoE deficiency. Adoptive transfer of CD45.2 monocytes to congenic CD45.1 mice demonstrated recruitment of Ly-6Chi monocytes to atherosclerotic aortas followed by local, rapid differentiation into macrophages; this was confirmed by labeling of splenic monocytes with [111In]oxine and localized by autoradiography. Transfer studies with CCR2-KO mice confirmed that CCR2 was required.
It is not clear whether the glycosylphosphatidylinositol-linked (GPI-linked) protein Ly-6C is a marker or functional receptor/ligand for an adhesin on endothelial cells and whether it or its human equivalent provides a potential target for inhibition of monocytosis and associated atherosclerosis. Future studies should establish whether CD14++CD16– monocytosis is an etiological factor in human disease.
Tacke et al. (4) used a similar apoE–/–-plus-diet model and also observed monocytosis with increased frequency of Gr-1hi monocytes (their Gr-1 mAb reacts with an epitope on both Ly-6C and Ly-6G, expressed on granulocytes as well). They employed an i.v. labeling method to mark blood monocyte subsets by phagocytosis of 0.5-μm latex particles. A portion of Gr-1lo monocytes in apoE–/– mice can be specifically and efficiently labeled for more than 5 days; Gr-1hi monocytes were labeled by a modification of this procedure, wherein monocytes are transiently depleted by clodronate-loaded liposomes prior to latex injection. Latex is then transferred to bone marrow, and labeled Gr-1hi monocytes appear in the circulation after 2 days, remaining Gr-1hi for 4 days before converting into Gr-1lo cells by 7 days. Normalization of numbers and cell clearance made it possible to compare the tracking of cells of each subset into lesions; the labeling procedure itself did not affect cellular recruitment. Though both subsets entered plaques, initial entry of Gr-1hi monocytes was approximately 20-fold greater than that of Gr-1lo cells, after normalization for frequency of labeled cells. A fat-rich diet increased rates of recruitment of both subsets. Another observation was that a subpopulation of cells expressing CD68, a pan-macrophage/DC marker, was CD11c+ and that Gr-1lo monocytes were particularly predisposed to become CD11c+ cells.
Further studies examined the role of chemokine receptors in recruitment. Surgical transfer of donor atherosclerotic aortic arches was used to take advantage of different knockout strains lacking CCR2 and CX3CR1. CCR2 was shown to be required (it also plays a role in monocyte exit from the bone marrow). Unexpectedly, Gr-1hi monocyte entry into plaques also depended on CX3CR1, and a potential ligand for this receptor, CX3CL1, was detected on endothelium overlying plaques. Xenogeneic in vitro experiments with HUVECs confirmed that Gr-1hi mouse monocytes required both CCR2 and CX3CR1 for in vitro migration. Finally, mAb depletion studies were used to implicate CCR5, in part, in monocyte migration to plaques.
The overall conclusion was that multiple chemokine receptors operate to control the migration of monocyte populations. This study identified a role for CX3CR1, not previously found in acute inflammatory models, giving rise to speculation that CX3CR1 may be selectively involved in atherosclerotic plaque recruitment, whereas CCR2 is more widely required in response to different types of inflammatory stimuli (4). This may account for the observation that polymorphism in human CX3CR1 leads to relative protection from cardiovascular disease (14).
In the third article, Lumeng et al. (5) restricted their studies to analysis of the macrophage phenotype in lean and adipose tissue of wild-type apoE+/+ C57BL/6 mice. Obesity and insulin resistance were induced in male mice, which were fed a high-fat diet consisting of 45% of calories derived from fat, starting at 8 weeks of age, for up to 20 weeks. Control mice were fed a standard diet consisting of 4.5% of calories derived from fat. Epididymal fat pads were extracted and the stromal vascular fraction isolated after removal of adipocytes by flotation. Digested preparations were analyzed by FACS, using F4/80 and CD11b to identify macrophages, which could be isolated by magnetic immunoaffinity-positive selection.
Adipose tissue from lean mice contained macrophages that expressed several markers of alternative activation, including IL-10 as well as enhanced levels of Ym1, arginase, and mannose receptor (5). By contrast, macrophages isolated from adipose tissue of obese mice exhibited a proinflammatory phenotype, overexpressing IL-6, NOS2, and CCR2; this chemokine receptor was required for diet-induced but not constitutive cell recruitment, as shown with CCR2-KO mice. In addition, some of the recruited macrophages expressed the CD11c antigen, although no further attempt was made in the present study to examine other possible DC markers. It was shown that IL-10, which was overexpressed in lean mice, protected adipocytes from TNF-α–induced insulin resistance in vitro. Leptin-deficient ob/ob mice showed a similar increase in F4/80+CD11c+CD11b+ cells.
These studies are consistent with a role for CCR2 in the diet-induced recruitment of monocytes that acquired a proinflammatory phenotype, gradually replacing a population with an alternative activation phenotype consisting of CCR2-independent macrophages that are slow to turn over. It is not clear which local stimuli might be responsible for either type of polarization, although lipid-derived metabolites are likely mediators of the proinflammatory phenotype. The nature and role of the CD11c+ cells also need to be investigated further. One limitation of these results is that ex vivo studies are not a precise reflection of cellular heterogeneity in vivo, although a limited immunocytochemical analysis was performed. This must be done with great care, since, in my own experience, adipose tissue is prone to stain nonspecifically with a range of mAbs. The potentially important surface and metabolic interactions among adipocytes, monocytes, macrophages, endothelial, and other stromal cells also deserve further investigation.
These intriguing studies have yielded further insights into the complexity of monocytes and tissue macrophages and the role of different chemokine receptors in constitutive and lipid-induced recruitment (summarized in Figure 2). It is clear that enhanced recruitment induced by metabolic and infectious inflammatory stimuli differs in important aspects that need better definition, in view of their importance in modified, often chronic inflammatory disease processes such as diabetes, as well as atherosclerosis. The nature of monocyte/macrophage heterogeneity is also difficult to assess due to the considerable plasticity of macrophages, their repertoire of receptors and extensive biosynthetic capacity. Furthermore, it is important not to overinterpret the expression of a single marker, such as CD11c, as indicative of DC differentiation. A panel of markers should be investigated, in situ if possible, and even then in relation to the complexity of macrophage differentiation and modulation in different tissue microenvironments. As to possible therapeutic exploitation, further investigation is required before different subsets of cells can be selectively, efficiently, and safely targeted. The availability of well-characterized experimental mouse models, as described in the articles under discussion, makes this an attractive goal. Their possible relevance to human disease poses further challenges for pathophysiological, translational research.
Monocyte and macrophage recruitment and response to tissue lipids. Summary of findings reported in the present studies (3–5). It is not clear whether individual monocytes express all markers and whether cells of each subset are recruited stochastically from the circulation. Some markers are not shown, which reflects lack of study rather than absence of expression. See text for role of Gr-1lo cells in atherosclerosis and in the generation of CD11c– cells. CCR5 involvement is partial (part; see text).
I thank my colleagues for the work done in my laboratory that contributed to this commentary. Research is supported by the Medical Research Council UK, the Wellcome Trust, the British Heart Foundation, and the Arthritis Research Campaign.
Nonstandard abbreviations used: CCR2, C-C motif chemokine receptor 2; CX3CR1, C-X3-C motif chemokine receptor 1.
Conflict of interest: The author has declared that no conflict of interest exists.
Reference information: J. Clin. Invest.117:89–93 (2007). doi:10.1172/JCI30992.
See the related articles at Obesity induces a phenotypic switch in adipose tissue macrophage polarization, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques, and Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.